Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
bladder | 100% | 8971.29 | 21 / 21 | 99% | 144.69 | 499 / 504 |
lung | 99% | 6347.95 | 573 / 578 | 99% | 72.95 | 1144 / 1155 |
uterus | 98% | 5521.82 | 167 / 170 | 99% | 132.89 | 454 / 459 |
esophagus | 97% | 10815.03 | 1399 / 1445 | 98% | 81.62 | 179 / 183 |
ovary | 99% | 7460.31 | 178 / 180 | 95% | 50.87 | 407 / 430 |
intestine | 96% | 5217.16 | 926 / 966 | 98% | 54.10 | 514 / 527 |
breast | 97% | 5993.93 | 446 / 459 | 89% | 40.72 | 992 / 1118 |
stomach | 89% | 4086.31 | 318 / 359 | 97% | 47.23 | 276 / 286 |
kidney | 85% | 2846.46 | 76 / 89 | 97% | 50.28 | 874 / 901 |
skin | 95% | 10175.10 | 1727 / 1809 | 81% | 31.15 | 381 / 472 |
prostate | 78% | 2774.31 | 192 / 245 | 94% | 49.72 | 472 / 502 |
thymus | 87% | 3034.60 | 565 / 653 | 85% | 33.35 | 517 / 605 |
liver | 69% | 3491.11 | 156 / 226 | 84% | 34.76 | 343 / 406 |
pancreas | 36% | 1006.12 | 118 / 328 | 97% | 94.77 | 172 / 178 |
adrenal gland | 53% | 1336.18 | 138 / 258 | 71% | 24.78 | 164 / 230 |
brain | 22% | 493.89 | 589 / 2642 | 82% | 29.57 | 581 / 705 |
lymph node | 0% | 0 | 0 / 0 | 100% | 238.08 | 29 / 29 |
spleen | 100% | 7933.49 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 97.55 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 345.16 | 1 / 1 |
peripheral blood | 97% | 10943.79 | 905 / 929 | 0% | 0 | 0 / 0 |
adipose | 97% | 11254.69 | 1168 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 87% | 3626.47 | 1167 / 1335 | 0% | 0 | 0 / 0 |
heart | 76% | 3929.06 | 651 / 861 | 0% | 0 | 0 / 0 |
muscle | 60% | 2326.19 | 478 / 803 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 14% | 2.48 | 11 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_1902033 | Biological process | regulation of hematopoietic stem cell proliferation |
GO_0060045 | Biological process | positive regulation of cardiac muscle cell proliferation |
GO_1905062 | Biological process | positive regulation of cardioblast proliferation |
GO_1990748 | Biological process | cellular detoxification |
GO_0043433 | Biological process | negative regulation of DNA-binding transcription factor activity |
GO_0045824 | Biological process | negative regulation of innate immune response |
GO_0043066 | Biological process | negative regulation of apoptotic process |
GO_0045893 | Biological process | positive regulation of DNA-templated transcription |
GO_0090336 | Biological process | positive regulation of brown fat cell differentiation |
GO_0050821 | Biological process | protein stabilization |
GO_0006915 | Biological process | apoptotic process |
GO_0006468 | Biological process | protein phosphorylation |
GO_0070561 | Biological process | vitamin D receptor signaling pathway |
GO_0046777 | Biological process | protein autophosphorylation |
GO_1904263 | Biological process | positive regulation of TORC1 signaling |
GO_0022898 | Biological process | regulation of transmembrane transporter activity |
GO_0071346 | Biological process | cellular response to type II interferon |
GO_0005730 | Cellular component | nucleolus |
GO_0005886 | Cellular component | plasma membrane |
GO_0005654 | Cellular component | nucleoplasm |
GO_0005829 | Cellular component | cytosol |
GO_0005737 | Cellular component | cytoplasm |
GO_0005634 | Cellular component | nucleus |
GO_0008134 | Molecular function | transcription factor binding |
GO_0106310 | Molecular function | protein serine kinase activity |
GO_0043024 | Molecular function | ribosomal small subunit binding |
GO_0004674 | Molecular function | protein serine/threonine kinase activity |
GO_0030145 | Molecular function | manganese ion binding |
GO_0005524 | Molecular function | ATP binding |
GO_0005515 | Molecular function | protein binding |
Gene name | PIM1 |
Protein name | Serine/threonine-protein kinase pim-1 (EC 2.7.11.1) |
Synonyms | |
Description | FUNCTION: Proto-oncogene with serine/threonine kinase activity involved in cell survival and cell proliferation and thus providing a selective advantage in tumorigenesis . Exerts its oncogenic activity through: the regulation of MYC transcriptional activity, the regulation of cell cycle progression and by phosphorylation and inhibition of proapoptotic proteins (BAD, MAP3K5, FOXO3) . Phosphorylation of MYC leads to an increase of MYC protein stability and thereby an increase of transcriptional activity (By similarity). The stabilization of MYC exerted by PIM1 might explain partly the strong synergism between these two oncogenes in tumorigenesis (By similarity). Mediates survival signaling through phosphorylation of BAD, which induces release of the anti-apoptotic protein Bcl-X(L)/BCL2L1 (By similarity). Phosphorylation of MAP3K5, another proapoptotic protein, by PIM1, significantly decreases MAP3K5 kinase activity and inhibits MAP3K5-mediated phosphorylation of JNK and JNK/p38MAPK subsequently reducing caspase-3 activation and cell apoptosis . Stimulates cell cycle progression at the G1-S and G2-M transitions by phosphorylation of CDC25A and CDC25C . Phosphorylation of CDKN1A, a regulator of cell cycle progression at G1, results in the relocation of CDKN1A to the cytoplasm and enhanced CDKN1A protein stability . Promotes cell cycle progression and tumorigenesis by down-regulating expression of a regulator of cell cycle progression, CDKN1B, at both transcriptional and post-translational levels . Phosphorylation of CDKN1B, induces 14-3-3 proteins binding, nuclear export and proteasome-dependent degradation . May affect the structure or silencing of chromatin by phosphorylating HP1 gamma/CBX3 . Acts also as a regulator of homing and migration of bone marrow cells involving functional interaction with the CXCL12-CXCR4 signaling axis (By similarity). Acts as a positive regulator of mTORC1 signaling by mediating phosphorylation and inhibition of DEPDC5 component of the GATOR1 complex . Acts as a negative regulator of innate immunity by mediating phosphorylation and inactivation of GBP1 in absence of infection: phosphorylation of GBP1 induces interaction with 14-3-3 protein sigma (SFN) and retention in the cytosol . Also phosphorylates and activates the ATP-binding cassette transporter ABCG2, allowing resistance to drugs through their excretion from cells . Promotes brown adipocyte differentiation (By similarity). . |
Accessions | ENST00000373509.6 [P11309-1] P11309 |